Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 9 Jan 20 424B4 Prospectus supplement with pricing info
- 9 Jan 20 EFFECT Notice of effectiveness
-
6 Jan 20 S-1 IPO registration
MIRM similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 18, 2019 (except for the third paragraph of Note 1, as to which the date is July 8, 2019), in the Registration Statement on FormS-1 and related Prospectus of Mirum Pharmaceuticals, Inc. for the registration of 2,760,000 shares of its common stock.
/s/ Ernst & Young LLP
Irvine, California
January 6, 2019